Arlington Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3
| Closed | -$2.47K | – | 362 |
|
|
2023
Q3 | $2.47K | Hold |
3
| – | – | ﹤0.01% | 270 |
|
|
2023
Q2 | $2.16K | Sell |
3
-10
| -77% | -$7.19K | ﹤0.01% | 531 |
|
|
2023
Q1 | $10.7K | Buy |
+13
| New | +$10.7K | ﹤0.01% | 413 |
|
|
2022
Q1 | – | Sell |
-21
| Closed | -$13K | – | 615 |
|
|
2021
Q4 | $13K | Sell |
21
-78
| -79% | -$48.3K | ﹤0.01% | 440 |
|
|
2021
Q3 | $60K | Buy |
+99
| New | +$60K | 0.02% | 241 |
|
|
2020
Q2 | – | Sell |
-15
| Closed | -$7K | – | 267 |
|
|
2020
Q1 | $7K | Buy |
15
+8
| +114% | +$3.73K | ﹤0.01% | 172 |
|
|
2019
Q4 | $3K | Buy |
+7
| New | +$3K | ﹤0.01% | 239 |
|
|
2019
Q1 | – | Sell |
-7
| Closed | -$3K | – | 233 |
|
|
2018
Q4 | $3K | Buy |
+7
| New | +$3K | ﹤0.01% | 198 |
|